Hong Kong Pharma Stock News

SEHK:100
SEHK:100Software

Assessing MiniMax Group’s Valuation After Strong Recent Share Price Momentum

MiniMax Group’s recent trading move and business snapshot MiniMax Group (SEHK:100) has drawn attention after a recent share price move, with a month return of 31.39% and 1 day and 7 day returns of 0.41% and 1.88% decline respectively. The company, founded in 2022 and based in George Town, Cayman Islands, designs and develops an artificial intelligence foundation model across text, audio, images, video, and music. See our latest analysis for MiniMax Group. MiniMax Group’s recent momentum is...
SEHK:86
SEHK:86Consumer Finance

Assessing Sun Hung Kai (SEHK:86) Valuation After Strong 2025 Earnings And Higher Dividend

Sun Hung Kai (SEHK:86) has drawn fresh attention after reporting full year 2025 results, with revenue of HK$5,473.6 million, net income of HK$1,593.1 million and a higher total dividend compared with 2024. See our latest analysis for Sun Hung Kai. At a share price of HK$4.25, Sun Hung Kai has seen a 6.52% 90 day share price return and a 45.33% 1 year total shareholder return, which may indicate momentum around the stronger earnings and higher dividend announcement. If the earnings story here...
SEHK:1810
SEHK:1810Tech

Assessing Whether Xiaomi (SEHK:1810) Looks Undervalued After A Mixed Recent Share Price Run

Assessing Xiaomi after a mixed share price run Xiaomi (SEHK:1810) has drawn fresh attention after a mixed share price stretch, with a 1.7% gain over the past day set against declines over the month and past 3 months. See our latest analysis for Xiaomi. Set against a 1-year total shareholder return decline of 35.36% and a 3-year total shareholder return above 170%, the recent negative 3-month share price return suggests momentum has cooled after a much stronger earlier period. If Xiaomi has...
SEHK:9926
SEHK:9926Biotechs

Akeso (SEHK:9926) FY 2025 Loss Deepens Despite 2H Revenue Growth Challenging Bullish Narratives

Akeso (SEHK:9926) has reported FY 2025 results with second half revenue of C¥1.6b and a basic EPS loss of C¥0.60, while trailing 12 month revenue reached C¥3.1b against a net loss of C¥1.1b. The business has seen revenue move from C¥1.1b in 2H 2024 to C¥1.6b in 2H 2025, with basic EPS shifting from a loss of C¥0.32 to a loss of C¥0.60 over the same period, as investors weigh growth in the top line against persistent losses. Overall, the latest numbers point to expanding operations but...
SEHK:1357
SEHK:1357Interactive Media and Services

Meitu (SEHK:1357) Net Margin Jump To 25.4% Tests Bullish AI Earnings Narrative

Meitu (SEHK:1357) has just posted its FY 2025 first half scorecard, with revenue of CN¥1.8b and basic EPS of CN¥0.09, against a backdrop of trailing twelve month revenue of CN¥3.5b and EPS of CN¥0.20 that coincides with earnings growth of 97.9% over the past year. The company has seen revenue move from CN¥1.6b and EPS of CN¥0.07 in 1H 2024 to CN¥1.8b and EPS of CN¥0.09 in 1H 2025, while trailing net profit margin sits at 25.4% versus 14.9% a year earlier and sets up a margin story that...